Last reviewed · How we verify
Bioconjugate pneumococcal vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Bioconjugate pneumococcal vaccine (Bioconjugate pneumococcal vaccine) — LimmaTech Biologics AG.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bioconjugate pneumococcal vaccine TARGET | Bioconjugate pneumococcal vaccine | LimmaTech Biologics AG | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bioconjugate pneumococcal vaccine CI watch — RSS
- Bioconjugate pneumococcal vaccine CI watch — Atom
- Bioconjugate pneumococcal vaccine CI watch — JSON
- Bioconjugate pneumococcal vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Bioconjugate pneumococcal vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/bioconjugate-pneumococcal-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab